Our mission is to amplify the rare condition voice. One of the ways we achieve that is through collaborations across the community, from patients and caregivers to industry leaders in treatment research and development.
In this vein, Patient Worthy will publish sponsored rare disease content that impacts our community, on behalf of other organizations. We hope these efforts will achieve improved awareness, communication and engagement across the rare disease world.
Sponsored content ranges from promoting events on our events calendar, to publishing, curating or creating content on behalf of an organization. While we may promote events on behalf of an organization, we are not involved in the event planning or hosting, unless otherwise noted.
All sponsored and promotional content must embody our mission of providing relevant, vetted and valuable information to our rare disease audience. Any promotional collaboration will be highlighted in the post, with the name of the sponsoring organization. On social media, a collaboration will be indicated with #Collab.
To learn more about our collaborations, contact [email protected].
Latest Patient Worthy Articles
UK Approves Ztalmy (Ganaxolone) for CDKL5 Deficiency Disorder
Jessica Lynn
March 18, 2024
Read More »
Pitolisant for Prader-Willi Syndrome (PWS) Earns Orphan Drug Designation
Jessica Lynn
March 14, 2024
Read More »
PGN-EDO51 Granted Orphan Drug Designation for Duchenne Muscular Dystrophy (DMD)
Jessica Lynn
March 14, 2024
Read More »
March 23: Lee University to Host the 2024 65 Roses 5K for Cystic Fibrosis (CF) Awareness
Jessica Lynn
March 14, 2024
Read More »
CAR T Delivers Excellent Results for 15 Patients with Autoimmune Diseases
Rose Duesterwald
March 13, 2024
Read More »
Rheumatoid Arthritis: Six Biomarkers Could Indicate Cardiovascular Disease Risk
James Moore
March 13, 2024
Read More »